These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 21904029)
21. Crystal structures of Escherichia coli RecA in complex with MgADP and MnAMP-PNP. Xing X; Bell CE Biochemistry; 2004 Dec; 43(51):16142-52. PubMed ID: 15610008 [TBL] [Abstract][Full Text] [Related]
22. Interaction between the individual isoenzymes of pyruvate dehydrogenase kinase and the inner lipoyl-bearing domain of transacetylase component of pyruvate dehydrogenase complex. Tuganova A; Boulatnikov I; Popov KM Biochem J; 2002 Aug; 366(Pt 1):129-36. PubMed ID: 11978179 [TBL] [Abstract][Full Text] [Related]
23. Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Roche TE; Hiromasa Y Cell Mol Life Sci; 2007 Apr; 64(7-8):830-49. PubMed ID: 17310282 [TBL] [Abstract][Full Text] [Related]
24. Increased expression of hepatic pyruvate dehydrogenase kinases 2 and 4 in young and middle-aged Otsuka Long-Evans Tokushima Fatty rats: induction by elevated levels of free fatty acids. Bajotto G; Murakami T; Nagasaki M; Qin B; Matsuo Y; Maeda K; Ohashi M; Oshida Y; Sato Y; Shimomura Y Metabolism; 2006 Mar; 55(3):317-23. PubMed ID: 16483874 [TBL] [Abstract][Full Text] [Related]
25. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta. Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420 [TBL] [Abstract][Full Text] [Related]
26. High-affinity metal-binding site in beef heart mitochondrial F1ATPase: an EPR spectroscopy study. Zoleo A; Contessi S; Lippe G; Pinato L; Brustolon M; Brunel LC; Dabbeni-Sala F; Maniero AL Biochemistry; 2004 Oct; 43(41):13214-24. PubMed ID: 15476415 [TBL] [Abstract][Full Text] [Related]
27. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Sugden MC; Holness MJ Am J Physiol Endocrinol Metab; 2003 May; 284(5):E855-62. PubMed ID: 12676647 [TBL] [Abstract][Full Text] [Related]
28. Tissue-specific kinase expression and activity regulate flux through the pyruvate dehydrogenase complex. Klyuyeva A; Tuganova A; Kedishvili N; Popov KM J Biol Chem; 2019 Jan; 294(3):838-851. PubMed ID: 30482839 [TBL] [Abstract][Full Text] [Related]
29. Crystal structures of substrates and products bound to the phosphoglycerate kinase active site reveal the catalytic mechanism. Bernstein BE; Hol WG Biochemistry; 1998 Mar; 37(13):4429-36. PubMed ID: 9521762 [TBL] [Abstract][Full Text] [Related]
30. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group. Steuber H; Zentgraf M; Podjarny A; Heine A; Klebe G J Mol Biol; 2006 Feb; 356(1):45-56. PubMed ID: 16337231 [TBL] [Abstract][Full Text] [Related]
31. Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer. Nunes-Xavier CE; Mingo J; Emaldi M; Flem-Karlsen K; Mælandsmo GM; Fodstad Ø; Llarena R; López JI; Pulido R Front Oncol; 2022; 12():873516. PubMed ID: 35692804 [TBL] [Abstract][Full Text] [Related]
32. Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta. Aoki M; Yokota T; Sugiura I; Sasaki C; Hasegawa T; Okumura C; Ishiguro K; Kohno T; Sugio S; Matsuzaki T Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):439-46. PubMed ID: 14993667 [TBL] [Abstract][Full Text] [Related]
33. Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex. Tso SC; Kato M; Chuang JL; Chuang DT J Biol Chem; 2006 Sep; 281(37):27197-204. PubMed ID: 16849321 [TBL] [Abstract][Full Text] [Related]
34. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol. Kato M; Li J; Chuang JL; Chuang DT Structure; 2007 Aug; 15(8):992-1004. PubMed ID: 17683942 [TBL] [Abstract][Full Text] [Related]
35. Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate. Li J; Kato M; Chuang DT J Biol Chem; 2009 Dec; 284(49):34458-67. PubMed ID: 19833728 [TBL] [Abstract][Full Text] [Related]
36. Diverse mechanisms of inhibition of pyruvate dehydrogenase kinase by structurally distinct inhibitors. Mann WR; Dragland CJ; Vinluan CC; Vedananda TR; Bell PA; Aicher TD Biochim Biophys Acta; 2000 Jul; 1480(1-2):283-92. PubMed ID: 11004568 [TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of pyruvate dehydrogenase kinase. Jeong JY; Jeoung NH; Park KG; Lee IK Diabetes Metab J; 2012 Oct; 36(5):328-35. PubMed ID: 23130316 [TBL] [Abstract][Full Text] [Related]
38. Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase. Burk DL; Hon WC; Leung AK; Berghuis AM Biochemistry; 2001 Jul; 40(30):8756-64. PubMed ID: 11467935 [TBL] [Abstract][Full Text] [Related]
39. Crystal structure of an asymmetric complex of pyruvate dehydrogenase kinase 3 with lipoyl domain 2 and its biological implications. Devedjiev Y; Steussy CN; Vassylyev DG J Mol Biol; 2007 Jul; 370(3):407-16. PubMed ID: 17532006 [TBL] [Abstract][Full Text] [Related]